Regular follow-up is key to managing Age-Related Macular Degeneration (AMD) and preventing severe vision loss. The approach varies depending on the type (dry or wet) and the severity of the disease.
Detect progression to advanced forms (such as geographic atrophy or wet AMD).
Adjust preventive measures and supplements.
Early stage (small drusen): Every 12-24 months.
Intermediate stage (large drusen or pigmentary changes): Every 6-12 months.
Advanced geographic atrophy: Every 3-6 months.
✔ Visual acuity (monitoring changes in central vision).
✔ Amsler grid (home self-assessment to detect distortions).
✔ Optical coherence tomography (OCT) (assesses retinal thickness and atrophy).
✔ Dilated fundus examination (looks for new drusen or pigmentary changes).
Self-monitoring with Amsler grid (once a week).
AREDS2 supplements (if prescribed by the ophthalmologist).
UV and blue light protection (filtering glasses).
Lutein/zeaxanthin-rich diet (spinach, broccoli, corn).
Evaluate response to treatment (anti-VEGF injections).
Detect reactivation of neovascularization.
Active phase (after starting treatment): Every 4-8 weeks.
Stabilized Phase: Every 2-4 months.
✔ OCT (monitors edema, intraretinal, or subretinal fluid).
✔ Fluorescein/indocyanine green angiography (if occult neovessels are suspected).
✔ Visual acuity (to assess treatment efficacy).
Loading Phase: 3 consecutive monthly injections (Lucentis, Eylea, etc.).
Maintenance Phase: Customized intervals based on response ("treat and extend" or "PRN").
Sudden appearance of distortion (crooked lines).
Widening central dark spot.
Sudden vision loss.
In dry AMD: 10-20% progress to wet AMD; early detection saves vision.
In wet AMD: Skipping check-ups or injections increases the risk of blindness.